Based on the present data from a prospective exploratory imaging trial, we could demonstrate a strong association between IL-6 plasma levels and PET imaging-derived tumor hypoxia dynamics in patients undergoing chemoradiation for locally advanced HNSCC. This evidence concerns the gene IL6 and neoplasm.